Novartis India board approves Minipress trademark acquisition from Pfizer
Novartis India said its board approved buying the Minipress and Minipres trademarks in India, plus related IP rights, from Pfizer Inc and Pfizer Products Inc, for ₹1,250 crore.
Novartis India said on Monday, September 7, that its board has approved the acquisition of the trademarks 'Minipress' and 'Minipres' registered in India, along with certain related intellectual property rights, from Pfizer Inc, USA, and Pfizer Products Inc, USA.The transaction will involve a total…